Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cellular maturation in human preleukemia.

H P Koeffler, D W Golde

    Blood
    |August 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Preleukemic cells with chromosomal abnormalities can mature in vitro. This suggests preleukemia involves ineffective hematopoiesis rather than a complete block in cell development.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Survival Experience of 195 Patients with Hairy Cell Leukemia Treated in a Multi-Institutional Study with Interferon-Alfa 2B.

    Leukemia & lymphoma·2016
    Same author

    Medical aid to honduras.

    Canadian Medical Association journal·2010
    Same author

    Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke.

    Proceedings of the National Academy of Sciences of the United States of America·2001
    Same author

    Mechanism of vitamin C inhibition of cell death induced by oxidative stress in glutathione-depleted HL-60 cells.

    The Journal of biological chemistry·2001
    Same author

    The predicted ATP-binding domains in the hexose transporter GLUT1 critically affect transporter activity.

    Biochemistry·2001
    Same author

    Direct inhibition of the hexose transporter GLUT1 by tyrosine kinase inhibitors.

    Biochemistry·2001
    Same journal

    Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

    Blood·2026
    Same journal

    Identifying steroid-refractory aGVHD before it happens.

    Blood·2026
    Same journal

    ELISA-negative HIT: antibody recognition and relevance.

    Blood·2026
    Same journal

    EBV and immunodeficiency: the odd couple drawn to the brain.

    Blood·2026
    Same journal

    A bone to pick with ferric carboxymaltose.

    Blood·2026
    Same journal

    A step toward streamlining HIT diagnosis.

    Blood·2026
    See all related articles

    Area of Science:

    • Hematology
    • Oncology
    • Cell Biology

    Background:

    • Preleukemia is characterized by karyotypic abnormalities in bone marrow cells.
    • The capacity of preleukemic clones to mature is not fully understood.

    Purpose of the Study:

    • To investigate the in vitro maturation potential of preleukemic bone marrow cells.
    • To correlate cytogenetic abnormalities with cellular maturation.

    Main Methods:

    • Liquid culture of bone marrow cells from three preleukemic patients.
    • Parallel cytogenetic and cytologic analyses of cultured cells.
    • Assessment of morphologic, cytochemical, and functional maturation markers.

    Main Results:

    • Delayed but significant maturation was observed in all cultures.

    Related Experiment Videos

  • By 21 days, 85% of cells showed evidence of maturation.
  • Cultured cells retained their characteristic chromosomal abnormalities.

    • Conclusions:

    • Preleukemic cells with chromosomal abnormalities can mature in vitro.
    • Preleukemia may represent a state of ineffective hematopoiesis.
    • Progressive abnormality in hematopoietic cell differentiation leads to acute myelogenous leukemia.